Betahistine dihydrochloride iglitazone Maleate Smiles: CC1=C(/C=C(\C#N)/C(=O)NC2=CC(Br)=CC=C2)C=C(C)N1C1C=CC(=CC=1)C(O)=O

Smiles: CC1=C(/C=C(\C#N)/C(=O)NC2=CC(Br)=CC=C2)C=C(C)N1C1C=CC(=CC=1)C(O)=O

InChiKey: JVHXJTBJCFBINQ-ADAARDCZSA-N

CAS Number: 74226-22-5

2012 Aug 3

CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC(O)=O |^1:0|

Betahistine dihydrochloride iglitazone Maleate Smiles: CC1=C(/C=C(\C#N)/C(=O)NC2=CC(Br)=CC=C2)C=C(C)N1C1C=CC(=CC=1)C(O)=OBetahistine is a histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. Betahistine dihydrochloride is an anti vertigo drug. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms associated with Mnire's disease. It was first registered in Europe in 1970 for the treatment of Mnire's disease. Product